Autobio Diagnostics Co., Ltd. (SHA:603658)
32.67
+0.80 (2.51%)
Jul 15, 2026, 1:05 PM CST
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 18.21 billion as of July 14, 2026. Its market cap has decreased by -14.85% in one year.
Market Cap
18.21B
Enterprise Value
17.39B
Revenue
4.22B
Ranking
n/a
PE Ratio
17.61
Stock Price
32.67
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 18.21B, an increase of 106.48%. That is a compound annual growth rate of 7.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 18.21B | -10.02% |
| Dec 31, 2025 | 20.24B | -18.93% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| APT Medical | 28.91B |
| Jiangsu Yuyue Medical Equipment & Supply | 25.97B |
| MGI Tech | 23.31B |
| Lepu Medical Technology (Beijing) | 22.67B |
| Double Medical Technology | 18.30B |
| MeHow Innovative | 15.89B |
| Shandong Weigao Blood Purification Products | 14.05B |
| Jafron Biomedical | 12.43B |